Financhill
Back

Axcelis Technologies Vs. Cytokinetics Industry Stock Comparison

Buy
62

ACLS
Axcelis Technologies

Last Price:
141.06
Seasonality Move:
-2.43%
Sell
49

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%
Buy
62
Axcelis Technologies (ACLS) is a Buy

Is Axcelis Technologies a Buy, Sell or Hold?

  • The current Axcelis Technologies [ACLS] share price is $141.19. The Score for ACLS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ACLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $52.87. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACLS Stock Price Chart

What is Axcelis Technologies's stock price today?

  • The Axcelis Technologies share price today is $141.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $52.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

ACLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.17 Buy
Relative Strength Index (14 RSI): 68.56 Buy
Chaikin Money Flow: 340305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.13 - 136.43) Buy
Bollinger Bands (100): (103.96 - 125.36) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 45.39 Sell
Chaikin Money Flow: -818137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.05 - 56.05) Buy
Bollinger Bands (100): (56.12 - 74.74) Sell

ACLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 138.63 Buy
20-day SMA: 127.9 Buy
50-day SMA: 115.47 Buy
200-day SMA: 127.27 Buy
8-day EMA: 136.8 Buy
20-day EMA: 129.96 Buy
50-day EMA: 121.22 Buy
200-day EMA: 123.77 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.93 Sell
20-day SMA: 51.83 Buy
50-day SMA: 58.36 Sell
200-day SMA: 55.81 Sell
8-day EMA: 52.98 Sell
20-day EMA: 53.53 Sell
50-day EMA: 57.52 Sell
200-day EMA: 56.86 Sell

Axcelis Technologies Earnings Growth & ACLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.25 per share, and an increase next year of $1.98 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.15 per share.

Axcelis Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):